85 related articles for article (PubMed ID: 12060851)
21. Frameshift mutation at codon 642 of the hMLH1 gene in human endometrial cancer.
Fukushige S; Wakatsuki S; Nagase S; Horii A
Hum Mutat; 1996; 8(4):394-5. PubMed ID: 8956057
[No Abstract] [Full Text] [Related]
22. Primary adenocarcinomas of the lung in nonsmokers show a distinct pattern of allelic imbalance.
Wong MP; Lam WK; Wang E; Chiu SW; Lam CL; Chung LP
Cancer Res; 2002 Aug; 62(15):4464-8. PubMed ID: 12154056
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analysis of expression and allelotype of mismatch repair genes (hMLH1 and hMSH2) in bladder cancer.
Kassem HS; Varley JM; Hamam SM; Margison GP
Br J Cancer; 2001 Feb; 84(3):321-8. PubMed ID: 11161395
[TBL] [Abstract][Full Text] [Related]
24. Loss of hMLH1 expression is associated with less aggressive clinicopathological features in sporadic endometrioid endometrial adenocarcinoma.
Ju W; Park HM; Lee SN; Sung SH; Kim SC
J Obstet Gynaecol Res; 2006 Oct; 32(5):454-60. PubMed ID: 16984511
[TBL] [Abstract][Full Text] [Related]
25. Allelic imbalances in endometrial stromal neoplasms: frequent genetic alterations in the nontumorous normal-appearing endometrial and myometrial tissues.
Moinfar F; Kremser ML; Man YG; Zatloukal K; Tavassoli FA; Denk H
Gynecol Oncol; 2004 Dec; 95(3):662-71. PubMed ID: 15581979
[TBL] [Abstract][Full Text] [Related]
26. [Genetic diagnosis of endometrial cancer].
Kanaya T; Kyo S; Maida Y; Inoue M
Nihon Rinsho; 2004 Oct; 62 Suppl 10():295-8. PubMed ID: 15535254
[No Abstract] [Full Text] [Related]
27. Global DNA methylation in relation to hMLH1 and hMSH2 protein immunoreactivity in sporadic human endometrial carcinomas.
Miturski R; Postawski K; Semczuk A; Bogusiewicz M; Baranowski W; Jakowicki JA; Keith G
Int J Mol Med; 2003 May; 11(5):569-74. PubMed ID: 12684691
[TBL] [Abstract][Full Text] [Related]
28. Birt-Hogg-Dubé gene mutations in human endometrial carcinomas with microsatellite instability.
Fujii H; Jiang W; Matsumoto T; Miyai K; Sashara K; Ohtsuji N; Hino O
J Pathol; 2006 Jul; 209(3):328-35. PubMed ID: 16691634
[TBL] [Abstract][Full Text] [Related]
29. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
[TBL] [Abstract][Full Text] [Related]
30. Absence of mutations in DNA mismatch repair genes in sporadic endometrial tumors with microsatellite instability.
Lim PC; Tester D; Cliby W; Ziesmer SC; Roche PC; Hartmann L; Thibodeau SN; Podratz KC; Jenkins RB
Clin Cancer Res; 1996 Nov; 2(11):1907-11. PubMed ID: 9816148
[TBL] [Abstract][Full Text] [Related]
31. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
[TBL] [Abstract][Full Text] [Related]
32. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
[TBL] [Abstract][Full Text] [Related]
33. Mutational analysis of transforming growth factor beta receptor type II and DNA mismatch repair genes in sporadic endometrial carcinomas with microsatellite instability.
Ohwada M; Suzuki M; Saga Y; Suzuki T; Ikeda M; Yamada M; Sato I
Oncol Rep; 2000; 7(4):789-92. PubMed ID: 10854545
[TBL] [Abstract][Full Text] [Related]
34. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
[TBL] [Abstract][Full Text] [Related]
35. Genomic aberrations in carcinomas of the uterine corpus.
Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
[TBL] [Abstract][Full Text] [Related]
36. BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression.
Feng YZ; Shiozawa T; Miyamoto T; Kashima H; Kurai M; Suzuki A; Konishi I
Clin Cancer Res; 2005 Sep; 11(17):6133-8. PubMed ID: 16144912
[TBL] [Abstract][Full Text] [Related]
37. Two Japanese kindreds occurring endometrial cancer meeting new clinical criteria for hereditary non-polyposis colorectal cancer (HNPCC), Amsterdam Criteria II.
Banno K; Susumu N; Hirao T; Yanokura M; Hirasawa A; Aoki D; Udagawa Y; Sugano K; Nozawa S
J Obstet Gynaecol Res; 2004 Aug; 30(4):287-92. PubMed ID: 15238104
[TBL] [Abstract][Full Text] [Related]
38. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples.
Wang YC; Lu YP; Tseng RC; Lin RK; Chang JW; Chen JT; Shih CM; Chen CY
J Clin Invest; 2003 Mar; 111(6):887-95. PubMed ID: 12639995
[TBL] [Abstract][Full Text] [Related]
40. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1.
Thibodeau SN; French AJ; Cunningham JM; Tester D; Burgart LJ; Roche PC; McDonnell SK; Schaid DJ; Vockley CW; Michels VV; Farr GH; O'Connell MJ
Cancer Res; 1998 Apr; 58(8):1713-8. PubMed ID: 9563488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
